Pebblebrook Trades at Half Its Net Asset Value. The Math Is Brutal.
Pebblebrook beat Q4 estimates and guided for RevPAR growth in 2026, but the stock still sits roughly 50% below the company's own NAV estimate of $23.50 per share. That gap tells a story about what the public markets actually think of urban hotel recovery, and owners holding similar assets should be paying attention.
Pebblebrook closed 2025 with $1.48 billion in revenue, AFFO of $1.58 per diluted share (beating outlook by $0.05), and same-property RevPAR growth of 2.9% in Q4. The headline numbers look like a company moving in the right direction. The stock price says the market doesn't believe the trajectory holds. Shares trading near $12 against a stated NAV of $23.50 is a 49% discount. That's not a rounding error. That's the market pricing in structural doubt about the durability of urban upper-upscale recovery.
Let's decompose what "rebound and reset" actually means here. San Francisco delivered 37.9% RevPAR growth in Q4 and a 58.5% Hotel EBITDA increase for full-year 2025. Impressive until you remember the denominator. San Francisco was the worst-performing major hotel market in the country for three consecutive years. A 58% gain on a deeply depressed base still leaves you short of 2019 economics in most cases. The portfolio shift tells the real story: San Francisco went from the company's largest market to 7% of Hotel EBITDA, while San Diego climbed to 23% and resorts now generate 48% of EBITDA (up from 17% in 2019). Pebblebrook didn't just wait for urban to come back. They repositioned around the possibility that it wouldn't come back fast enough.
The capital structure is cleaner than it was. A new $450 million term loan due 2031 replaced the $360 million 2027 maturity, and 98% of debt is effectively fixed at a weighted average of 4.1%. That's competent treasury management. The $71.3 million in share repurchases at $11.37 average makes mathematical sense when you believe your NAV... you're buying $23.50 of assets for $11.37. But the 2026 guidance still includes a scenario where net income is negative ($10.4 million loss at the low end). A company buying back stock while guiding toward potential losses is making a bet that the market is wrong about them. Sometimes that bet pays off. Sometimes the market is right.
The 2026 outlook calls for 2.25% to 4.25% same-property RevPAR growth and Adjusted FFO of $1.50 to $1.62 per share. At midpoint, that's roughly flat to 2025. The $65 to $75 million CapEx budget is slightly below 2025's $74.6 million, which makes sense given the $525 million redevelopment program is substantially complete. The question for anyone holding similar upper-upscale urban assets: what happens when the renovation lift is fully absorbed and you're competing on operations alone? The easy gains from repositioning are behind this portfolio. The next dollar of NOI growth has to come from rate power, occupancy, and expense discipline. That's harder.
CEO Bortz buying 15,000 shares in early March is a signal worth tracking, not overweighting. Insider purchases in a REIT trading at half NAV are practically obligatory from an optics standpoint. The Zacks upgrade from "strong sell" to "hold" is similarly modest... "hold" is not conviction. The real tell is flow-through. Pebblebrook grew Q4 same-property Hotel EBITDA 3.9% on 2.9% RevPAR growth. That's decent but not exceptional margin expansion. For a portfolio that just completed half a billion dollars in renovations, I'd want to see that spread widen. If it doesn't, the redevelopment thesis starts to compress.
Here's what I'd say to anyone running or owning upper-upscale urban assets right now. Pebblebrook just showed you the playbook and the limits of the playbook in the same earnings call. They spent $525 million repositioning, diversified away from their weakest markets, cleaned up the balance sheet... and the stock still trades at half of NAV. If you're an owner holding urban hotel assets with pre-pandemic debt assumptions baked into your capital stack, stress-test your NOI against a scenario where RevPAR growth stays in the 2-4% range for the next three years. Not a downturn... just a grind. That's what this guidance is telling you. This is what I call the Flow-Through Truth Test. Pebblebrook grew RevPAR 2.9% and EBITDA 3.9%... that spread needs to be wider after $525 million in capital. If your property just went through a renovation and you're not seeing meaningfully better flow-through, the renovation didn't reposition you. It just maintained you. Know the difference before your next asset management review.